This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Venom-derived compounds have produced successful drugs and represent a largely untapped source of stable molecules for difficult drug targets.
Why it matters
Many disease targets are too complex for traditional small molecules but too simple for antibodies. Venom peptides fill this gap.
The numbers in context
Approved drugs: exenatide, eptifibatide, echistatin; venom sources from 7+ animal groups
How the study worked
Review article covering venom biology, drug discovery examples, and challenges in developing venom-derived therapeutics.
Who was studied
Review article (no study population)
What this study cannot tell us
This is a review, not original research. Many venom compounds face challenges in oral absorption, manufacturing, and toxicity.
Read the original research
Utilisation of compounds from venoms in drug discovery.
Progress in medicinal chemistry, 60, 1-66
Citation
Trim, Carol M; Byrne, Lee J; Trim, Steven A. (2021). Utilisation of compounds from venoms in drug discovery.. Progress in medicinal chemistry, 60, 1-66. https://doi.org/10.1016/bs.pmch.2021.01.001